Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a).

已完结 10 由 QDX 发布于 2026/11/13 22:24:21

DOI:10.1056/NEJMoa2610159
作者：Leslie Cho,?Stephen J Nicholls,?Seth Frndak,?Kathy Wolski,?B?rge G Nordestgaard,?Brian Manning,?Eran Leitersdorf,?Ulf Landmesser,?Venu Menon,?Jackie McCluskey,?Michael J Blaha,?Ryuichi Morishita,?A Mi
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Pelacarsen, an antisense oligonucleotide, reduces serum levels of lipoprotein(a). However, the effect of pelacarsen on cardiovascular outcomes remains uncertain.Methods: We condu

应助信息

1小时前

肉肉

78e360dddf6e11f197ff208810ba6e4f.pdf 已采纳

1小时前

Book学术机器人

2026/11/13 22:24:21 未找到该文献，机器人已退出，请等待人工下载

2026/11/13 22:24:21 Book学术AI机器人收到请求，开始寻找文献

2026/11/13 22:24:21 已向机器人发送请求

1小时前

QDX 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:New England Journal of Medicine (NEJM)Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a).